Results 1 to 10 of about 117,132 (141)

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study [PDF]

open access: yesAntibiotics, 2022
This single-center historical cohort study investigated the effectiveness and safety of extended infusion (EI) compared with short-term infusion (STI) of meropenem in neonatal sepsis.
Guangna Cao   +5 more
doaj   +7 more sources

Development of the Extended Infusion Set and Its Mechanism of Action [PDF]

open access: yesJournal of Diabetes Science and Technology, 2022
Continuous subcutaneous insulin infusion (CSII, or insulin pump) and continuous glucose monitoring (CGM) sensors have been increasingly used and associated with improved glycemic control by people with type 1 diabetes and insulin-requiring type 2 diabetes. Commonly used infusion sets in most CSII systems are limited to a wear time of 3 days.
Ohad Cohen   +2 more
exaly   +4 more sources

Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia [PDF]

open access: yesDrug Design, Development and Therapy, 2017
Mohamed M Ibrahim,1 Tarek Fouad Tammam,2 Mohy El Deen Ebaed,3 Hatem A Sarhan,4 Gamal F Gad,5 Amal K Hussein4 1Department of Clinical Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt; 2Department of Anesthesia and Intensive Care, Faculty of ...
Ibrahim MM   +5 more
doaj   +7 more sources

Impact of extended-infusion piperacillin-tazobactam in a Canadian community hospital [PDF]

open access: yesInfectious Medicine, 2023
Background: Studies have demonstrated improved clinical outcomes with extended infusion (EI) piperacillin/tazobactam (TZP) compared to standard infusion (SI). However, there is less evidence on its benefits in noncritically-ill patients. Hospital-wide EI
April J. Chan   +8 more
doaj   +4 more sources

Pharmacokinetics of imipenem in critically ill patients: Continuous infusion versus extended infusion in a real-world study [PDF]

open access: yesJournal of International Medical Research
Objective This study compared the pharmacokinetic/pharmacodynamic properties of extended infusion and continuous infusion of imipenem at equivalent daily doses in a real-world setting.
Ruixia Zhang, Yi Qin, Yayao Lv, Yi Zhang
doaj   +4 more sources

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis. [PDF]

open access: yesPLoS ONE, 2018
BACKGROUND:Meropenem exhibits time-dependent antimicrobial activity and prolonged infusion (PI) (extended infusion or continuous infusion, EI or CI) of meropenem can better achieve pharmacodynamics target when comparing with intermittent bolus (IB ...
Zhenwei Yu   +4 more
doaj   +5 more sources

Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2023
Background: Extended infusion cefepime (1 gram every 6 hours administered over 3 hours) achieves pharmacodynamic efficacy against bacteria with a MIC of ≤8 mg/L in Monte Carlo simulations.
Aalok V. Khole   +3 more
doaj   +4 more sources

Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study [PDF]

open access: yesScientific Reports, 2022
Extended infusion of piperacillin/tazobactam over 4 h has been proposed as an alternate mode of administration to the 30-min intermittent infusion to optimize treatment effects in patients with gram-negative bacterial infections.
Christina Medhat Naiim   +3 more
doaj   +2 more sources

Extended infusion of β-lactams significantly reduces mortality and enhances microbiological eradication in paediatric patients: a systematic review and meta-analysisResearch in context [PDF]

open access: yesEClinicalMedicine, 2023
Summary: Background: Paediatric patients are often exposed to subtherapeutic levels or treatment failure of β-lactams, and prolonged infusion may be beneficial.
Kinga Anna Budai   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy